RxDoctor Payments Data

Rodwell Mabaera

Hematology · Lebanon, NHNPI 1417272279

Payments from drug & device makers

$158,289in general payments, 2019–2025

Across 10 payments — averaging $15,829 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$116K
  • Janssen Research & Development, LLC$25K
  • QED Therapeutics, Inc.$17K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck7$115,539
Janssen Research & Development, LLC2$25,340
QED Therapeutics, Inc.1$17,410

How this compares

Too few hematology providers in New Hampshireto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$64,829
Medicare patients
202
Services billed
689

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XtandiEnzalutamide60$905,039
Abiraterone Acetate155$614,746
CabometyxCabozantinib S-Malate12$211,123
EliquisApixaban16$5,900
Prednisone119$317

Paid to pharmacies, not to this prescriber.

Other hematology in Lebanon

Where these figures come from

Is this you, or does something look wrong? →